advanced search

EXPERT VIEW

BIOCOMPATIBILITY OF MEDICINAL PRODUCT MEDICAL DEVICE COMBINATIONS FOR AIRWAY DELIVERY
EXPERT VIEW
Mark Turner
BIOCOMPATIBILITY OF MEDICINAL PRODUCT MEDICAL DEVICE COMBINATIONS FOR AIRWAY DELIVERY
Mark Turner discusses biocompatibility testing for inhaled medical products, with particular reference to ISO 18562, and what Medical Engineering Technologies has learned from three years of breathing component biocompatibility testing.
NASAL DELIVERY: AN OPPORTUNITY FOR SIGNIFICANT IMPROVEMENTS IN PATIENT CARE
EXPERT VIEW
Dr Stuart Madden
NASAL DELIVERY: AN OPPORTUNITY FOR SIGNIFICANT IMPROVEMENTS IN PATIENT CARE
Stuart Madden discusses the advantages of the nasal route of administration for the systemic delivery of therapeutics.
FORMULATION OPTIONS IN NASAL DRUG DELIVERY
EXPERT VIEW
Dr Richard Johnson
FORMULATION OPTIONS IN NASAL DRUG DELIVERY
Richard Johnson discusses the advantages of nasal delivery and why there is growing interest in this route of administration, as well as considering some of the challenges that may arise during the development of nasal formulations for use in the clinic, and the regulatory and testing requirements associated with them.
CONSIDERATIONS FOR OPHTHALMIC DRUG DELIVERY AND DEVELOPMENT
EXPERT VIEW
Robert Lee
CONSIDERATIONS FOR OPHTHALMIC DRUG DELIVERY AND DEVELOPMENT
Robert Lee discusses recent advances in ophthalmic dosage forms and how companies are meeting these challenges to better serve their customers.
DRUG DELIVERY TO THE EYE: OVERCOMING THE CHALLENGES OF INTRAVITREAL PREFILLED SYRINGES
EXPERT VIEW
Dr Suresh Gupta
DRUG DELIVERY TO THE EYE: OVERCOMING THE CHALLENGES OF INTRAVITREAL PREFILLED SYRINGES
Suresh Gupta discusses the challenges of developing a PFS product for intravitreal injection, highlighting how designing for the intravitreal space, rather than the standard parenteral, imposes a number of additional requirements on the design.
LINKING THE “D” & “M” IN CDMO
EXPERT VIEW
Mr John Ross
LINKING THE “D” & “M” IN CDMO
John Ross looks at the role of CDMOs in product development through to commercialisation and considers the benefits of consolidated “DM” models.
ROOM FOR INNOVATION?
EXPERT VIEW
Darren Mansell
ROOM FOR INNOVATION?
Darren Mansell examines US FDA guidance on biosimilar interchangeability and asks whether there is room for innovation.
TOP FIVE DRUG DELIVERY TRENDS FOR 2021
EXPERT VIEW
Tom Oakley
TOP FIVE DRUG DELIVERY TRENDS FOR 2021
Tom Oakley provides an overview of the top five trends to expect in drug delivery in 2021.
TACKLING PARENTERAL DRUG LABELLING’S SURGING COMPLEXITY
EXPERT VIEW
Lars Skole
TACKLING PARENTERAL DRUG LABELLING’S SURGING COMPLEXITY
Lars Skole discusses emerging trends and challenges associated with growing parenteral packaging and labelling complexity – and how pharmaceutical developers and manufacturers can meet the challenges ahead.
CONNECTED DRUG DELIVERY: ACHIEVING OPTIMAL BENEFITS THROUGH SMART COLLABORATION
EXPERT VIEW
George I’ons
CONNECTED DRUG DELIVERY: ACHIEVING OPTIMAL BENEFITS THROUGH SMART COLLABORATION
George I’ons discusses the challenges developing connected devices presents to key market stakeholders when it comes to successful rollout and implementation. Additionally, he considers the perspectives of these market players, as well as the patients themselves, with respect to how connected drug delivery devices can help them to better achieve their desired outcomes.
ECONOMIC OPERATORS UNDER THE EU MDR: THE NEW REQUIREMENTS
EXPERT VIEW
Beth Crandall
ECONOMIC OPERATORS UNDER THE EU MDR: THE NEW REQUIREMENTS
Beth Crandall spells out the new requirements for Economic Operators under the EU Medical Device Regulation.
PREPARING FOR MASS VACCINATION
EXPERT VIEW
Andy Fry
PREPARING FOR MASS VACCINATION
Andy Fry and Stephen Blatcher discuss the need for a mass vaccination device in response to the 2020 covid-19 pandemic. In particular, the authors discuss the benefits and challenges of turning to needle-free injection technology as a solution.
CONDUCTING EFFECTIVE AND INFORMATIVE EVALUATIONS OF INJECTION DEVICE PACKAGING
EXPERT VIEW
Allison Strochlic
CONDUCTING EFFECTIVE AND INFORMATIVE EVALUATIONS OF INJECTION DEVICE PACKAGING
Allison Strochlic and Andrea Dwyer discuss the often overlooked aspect of a combination product user interface: the packaging. With a specific look at injection devices, the authors cover how to perform proper human factors testing of a combination product’s packaging, and the advantages doing so can confer to a project.
SUSTAINABLE PHARMACEUTICALS CAN OUTPERFORM THROUGH NATURALLY DERIVED INGREDIENTS & DEEP EXPERTISE
EXPERT VIEW
Rina Chokshi
SUSTAINABLE PHARMACEUTICALS CAN OUTPERFORM THROUGH NATURALLY DERIVED INGREDIENTS & DEEP EXPERTISE
Rina Chokshi discusses the benefits of naturally derived, sustainable ingredients and their benefits to the environment and pharmaceutical industry.
RETHINKING DRUG DELIVERY DEVICES FOR SUSTAINABILITY AND INNOVATION
EXPERT VIEW
Sergio Malorni
RETHINKING DRUG DELIVERY DEVICES FOR SUSTAINABILITY AND INNOVATION
Sergio Malorni and George Bostock discuss the issue of designing for sustainability, including going beyond “Reduce, Reuse, Recycle” to “Rethink” and looking to adjacent and consumer industries for inspiration on innovations the drug delivery industry can adopt with a view to reducing its environmental impact.
SUSTAINABILITY AND DRUG DELIVERY DEVICES
EXPERT VIEW
Rob Veasey
SUSTAINABILITY AND DRUG DELIVERY DEVICES
Rob Veasey explores the environmental challenges facing the drug delivery device industry – and the opportunities they bring.
WEARABLE INJECTORS: LATEST DEVICES & RECENT TRENDS
EXPERT VIEW
Tom Oakley
WEARABLE INJECTORS: LATEST DEVICES & RECENT TRENDS
Wearable injection device expert Tom Oakley discusses recent trends in the space. He also takes a look at wearable injection devices currently on the market and considers the future of wearable injectors.
ADVANCED CAPSULE TECHNOLOGIES: DRY POWDER INHALERS TO TARGET DISEASE
EXPERT VIEW
Frédérique Bordes-Picard
ADVANCED CAPSULE TECHNOLOGIES: DRY POWDER INHALERS TO TARGET DISEASE
Frédérique Bordes-Picard  and Julien Lamps discuss the value of capsule-based dry powder inhalers in the modern respiratory market, the factors driving development in this area and considerations for matching a capsule to a device and formulation.
THE RISE OF COMPLEX ORAL DELIVERY SYSTEMS
EXPERT VIEW
María FM Balson
THE RISE OF COMPLEX ORAL DELIVERY SYSTEMS
María Fernández-Martos Balson and Bastiaan De Leeuw explore the oral delivery of biologics and the challenges that must be overcome in order to enhance bioavailability. The authors also take a look at some recently developed drug-device combinations.
COVID-19: A CATALYST FOR IMPLEMENTING CONNECTED HEALTHCARE PRODUCTS?
EXPERT VIEW
Napoleon Monroe
COVID-19: A CATALYST FOR IMPLEMENTING CONNECTED HEALTHCARE PRODUCTS?
Napoleon Monroe analyses how covid-19 is catalysing a wide range of reactions in healthcare, explaining how drug and device connectivity are essential to improving patient access to treatment – and patient outcomes – as well as reducing overall cost. 
RISKS AND REAL-WORLD SOLUTIONS FOR CONNECTED MEDICAL DEVICES
EXPERT VIEW
Tom Oakley
RISKS AND REAL-WORLD SOLUTIONS FOR CONNECTED MEDICAL DEVICES
Tom Oakley discusses the risks surrounding the use of connected drug delivery devices – and the real-world solutions that have either been proved or are being trialled.
CONNECTED DEVICE DATA NEEDED TO MAKE HOME CARE THE STANDARD
EXPERT VIEW
Dr Andrei Yosef
CONNECTED DEVICE DATA NEEDED TO MAKE HOME CARE THE STANDARD
With home care on the increase as a result of the coronavirus pandemic, Andrei Yosef looks at the crucial role played by connected home care medical devices and the data they generate.
SENSOR ADVANCEMENTS IN DRUG DELIVERY IMPROVE COMPLIANCE
EXPERT VIEW
Salvatore Forte
SENSOR ADVANCEMENTS IN DRUG DELIVERY IMPROVE COMPLIANCE
Salvatore Forte discusses various advancements in sensors that are transforming drug delivery systems, making complex devices more automated, easier to use, and improving patient compliance as a result.
WHICH IS THE BETTER TOXICITY TESTING STRATEGY FOR COMBINATION DEVICES?
EXPERT VIEW
Mark Turner
WHICH IS THE BETTER TOXICITY TESTING STRATEGY FOR COMBINATION DEVICES?
Mark Turner explores the issue of toxicity testing for combination devices and asks which is the better testing strategy – ISO 10993 or extractables and leachables?
Top